TRVI — TREVI THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in TREVI THERAPEUTICS INC (TRVI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 26,598 -1,564 -5.6% 0.00% $243K $9.15
2025 Q2 INITIATED 28,162 — — 0.00% $154K $5.47
% of Fund (quarterly)    TRVI price (monthly, adj. close)

Other funds also holding TRVI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 9.1% NEA Management Company, LLC 3Y 7Y 8.44% Pivotal bioVenture Partners Investment Advisor LLC 3Y 6.08% MPM BioImpact LLC 3Y 4.71% Octagon Capital Advisors LP 3Y 4.28% Vivo Capital, LLC 3Y 7Y 4.12% Artia Global Partners LP 3Y 3.57% Frazier Life Sciences Management, L.P. 3Y 3.45% Affinity Asset Advisors, LLC 3Y 1.53% Velan Capital Investment Management LP 3Y 1.49%
← Back to Engineers Gate Manager LP Holdings